← Insider buys
APRE

Aprea Therapeutics, Inc. · Healthcare

5Am Ventures Iv, L.P. sold $9.0M of Aprea Therapeutics, Inc.

10% owner

Sold$8,963,250
$35.15Price
255,000Shares
−38%Stake

What APRE did after the filing

Prices for APRE after this filing aren't in yet.

Traded Tue, May 19. Filed Thu, May 21, 5:31 PM ET, after the close. Not investment advice.